TheraTech re-acquires some rights to patch:
This article was originally published in Clinica
Executive Summary
TheraTech, a developer of drug delivery products based in Salt Lake City, Utah, plans to re-acquire the marketing rights to its male testosterone patch from SmithKline Beecham in certain countries. SmithKline will continue to market the product in North America, the UK and Ireland.